Page last updated: 2024-08-25

ubenimex and Leukemia, Smoldering

ubenimex has been researched along with Leukemia, Smoldering in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukutani, H; Kimura, I; Miura, Y; Mizoguchi, H; Naoe, T; Ohno, R; Ohshima, T; Omine, M; Saito, H; Tomonaga, M	1
Saito, Y; Uzuka, Y	1

Trials

1 trial(s) available for ubenimex and Leukemia, Smoldering

Article	Year
Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine (ubenimex). Japanese journal of clinical oncology, 1991, Volume: 21, Issue:4 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aminopeptidases; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Child; Female; Humans; Leucine; Leukemia; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Prospective Studies	1991

Article

Year

Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine (ubenimex).

Japanese journal of clinical oncology, 1991, Volume: 21, Issue:4

Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aminopeptidases; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Child; Female; Humans; Leucine; Leukemia; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Prospective Studies

1991

Other Studies

1 other study(ies) available for ubenimex and Leukemia, Smoldering

Article	Year
[Bestatin treatment of patients with myelodysplastic syndromes]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:3 Pt 1 Topics: Adjuvants, Immunologic; Aged; Anemia, Refractory, with Excess of Blasts; Colony-Forming Units Assay; Female; Hematopoiesis; Humans; Leucine; Male; Middle Aged	1989